Page last updated: 2024-12-05

methylene bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylene bromide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dibromomethane : A member of the class of bromomethanes that is methane substituted by two bromo groups. It is produced by marine algae. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3024
CHEMBL ID1229889
CHEBI ID47077
SCHEMBL ID20033
MeSH IDM0090383

Synonyms (58)

Synonym
AKOS009031545
4371-77-1
CHEMBL1229889
dibromo-methane
nsc-7293
74-95-3
wln: e1e
methylene bromide
methane, dibromo-
nsc7293
dibromomethane
methylene dibromide
dibromomethylene
ccris 939
nsc 7293
ai3-52311
rcra waste number u068
hsdb 1334
un2664
einecs 200-824-2
brn 0969143
rcra waste no. u068
inchi=1/ch2br2/c2-1-3/h1h
2BM ,
dibromomethane, 99%
dibromomethane, analytical standard
dibromomethane, >=99%
methylenbromid
dibrommethan
ch2br2
CHEBI:47077 ,
D0192
S0636
NCGC00248598-01
cas-74-95-3
dtxcid401557
dtxsid4021557 ,
tox21_200410
NCGC00257964-01
STL282729
ec 200-824-2
v69b659w01 ,
dibromomethane [un2664] [poison]
unii-v69b659w01
4-01-00-00078 (beilstein handbook reference)
FT-0624675
methylene bromide [mi]
SCHEMBL20033
1,1-dibromomethane
dibromo methane
un 2664
J-520238
F1908-0088
mfcd00000168
dibromomethane, puriss., >=98.5% (gc)
dibromomethane, stabilized with bht
Q421736
AMY11088

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" First, permeability constants for dibromomethane (DBM), bromochloromethane (BCM), and methylene chloride (DCM) were calculated by using a physiologically based pharmacokinetic model for dihalomethanes to relate blood concentrations during dermal vapor exposures to the total amount of chemical which was absorbed through the skin."( A physiological pharmacokinetic model for dermal absorption of vapors in the rat.
Andersen, ME; Clewell, HJ; Jepson, GW; MacNaughton, MG; McDougal, JN, 1986
)
0.27

Bioavailability

ExcerptReferenceRelevance
" Biologically-based models can be used to simulate the absorption process and predict the rate of absorption and the amount of the chemical in various parts of the body and skin."( Parallel dermal subcompartments for modeling chemical absorption.
Bookout, RL; McDougal, JN; Quinn, DW, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
bromomethanesA halomethane that is methane in which one or more hydrogens has been replaced by bromine.
bromohydrocarbonA compound derived from a hydrocarbon by replacing a hydrogen atom with a bromine atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.02810.006038.004119,952.5996AID1159521
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.68000.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (25.00)18.7374
1990's14 (29.17)18.2507
2000's14 (29.17)29.6817
2010's7 (14.58)24.3611
2020's1 (2.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.81 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index115.77 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (69.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]